Conventional MR Imaging

Simon, 2006, Standardized MRI protocol for multiple sclerosis: Consortium of MS Centers (CMSC) consensus guidelines, AJNR Am J Neuroradiol, 27, 455 Filippi, 1997, The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis, Neurology, 49, 274, 10.1212/WNL.49.1.274 Rovaris, 1998, A comparison between the sensitivities of 3-mm and 5-mm thick serial brain MRI for detecting lesion volume changes in patients with multiple sclerosis, J Neuroimaging, 8, 144, 10.1111/jon199883144 Rydberg, 1995, Contrast optimization of fluid-attenuated inversion recovery (FLAIR) imaging, Magn Reson Med, 34, 868, 10.1002/mrm.1910340612 Filippi, 1996, Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS, Neurology, 46, 379, 10.1212/WNL.46.2.379 Silver, 1997, Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetization transfer contrast and delayed imaging, Brain, 120, 1149, 10.1093/brain/120.7.1149 Keiper, 1998, MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T, AJNR Am J Neuroradiol, 19, 1489 Wattjes, 2006, Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?, AJNR Am J Neuroradiol, 27, 1794 Lee, 1995, MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T, Radiology, 194, 257, 10.1148/radiology.194.1.7997564 Young, 1981, Nuclear magnetic resonance imaging of the brain in multiple sclerosis, Lancet, 2, 1063, 10.1016/S0140-6736(81)91273-3 Robertson, 1987, Assessment of multiple sclerosis lesions by magnetic resonance imaging, Can Assoc Radiol J, 38, 177 McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann Neurol, 50, 121, 10.1002/ana.1032 Brex, 2002, A longitudinal study of abnormalities on MRI and disability from multiple sclerosis, N Engl J Med, 346, 158, 10.1056/NEJMoa011341 Kira, 2003, Multiple sclerosis in the Japanese population, Lancet Neurol, 2, 117, 10.1016/S1474-4422(03)00308-9 Wingerchuk, 2005, Neuromyelitis optica, Curr Treat Options Neurol, 7, 173, 10.1007/s11940-005-0010-6 Stewart, 1986, Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation studies in eight cases, Neurology, 36, 320 Barnes, 1991, The longstanding MS lesion: a quantitative MRI and electron microscopic study, Brain, 114, 1271, 10.1093/brain/114.3.1271 Horowitz, 1989, The ovoid lesion: a new MR observation in patients with multiple sclerosis, AJNR Am J Neuroradiol, 10, 303 Pirko, 2007, Gray matter involvement in multiple sclerosis, Neurology, 68, 634, 10.1212/01.wnl.0000250267.85698.7a Geurts, 2005, Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging, Radiology, 236, 254, 10.1148/radiol.2361040450 Wattjes, 2007, Double inversion recovery brain imaging at 3 T: diagnostic value in the detection of multiple sclerosis lesions, AJNR Am J Neuroradiol, 28, 54 Nelson, 2007, Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging, AJNR Am J Neuroradiol, 28, 1645, 10.3174/ajnr.A0645 Geurts, 2005, Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology, AJNR Am J Neuroradiol, 26, 572 Kidd, 1999, Cortical lesions in multiple sclerosis, Brain, 122, 17, 10.1093/brain/122.1.17 Barkhof, 1997, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, 120, 2059, 10.1093/brain/120.11.2059 Gean-Marton, 1991, Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis, Radiology, 180, 215, 10.1148/radiology.180.1.2052698 Giroud, 1995, Clinical and topographical range of callosal infarction: a clinical and radiological correlation study, J Neurol Neurosurg Psychiatry, 59, 238, 10.1136/jnnp.59.3.238 Abe, 2002, Clinical features of CADASIL, Ann N Y Acad Sci, 977, 266, 10.1111/j.1749-6632.2002.tb04825.x Buhring, 2001, MRI features of primary central nervous system lymphomas at presentation, Neurology, 57, 393, 10.1212/WNL.57.3.393 Morgen, 2004, Central nervous system disease in primary Sjogren's syndrome: the role of magnetic resonance imaging, Semin Arthritis Rheum, 34, 623, 10.1016/j.semarthrit.2004.07.005 Whiteman, 1993, Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation, Radiology, 187, 233, 10.1148/radiology.187.1.8451420 Yetkin, 1991, Multiple sclerosis: specificity of MR for diagnosis, Radiology, 178, 447, 10.1148/radiology.178.2.1987607 Hunt, 1989, Clinical significance of MRI white matter lesions in the elderly, Neurology, 39, 1470, 10.1212/WNL.39.11.1470 de Leeuw, 2001, Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study, J Neurol Neurosurg Psychiatry, 70, 9, 10.1136/jnnp.70.1.9 van Swieten, 1991, Hypertension in the elderly is associated with white matter lesions and cognitive decline, Ann Neurol, 30, 825, 10.1002/ana.410300612 Takao, 1999, Pathologic findings of silent hyperintense white matter lesions on MRI, J Neurol Sci, 167, 127, 10.1016/S0022-510X(99)00158-6 Jungreis, 1988, Normal perivascular spaces mimicking lacunar infarction: MR imaging, Radiology, 169, 101, 10.1148/radiology.169.1.3420242 Williams, 1990, Neurosarcoidosis: gadolinium-enhanced MR imaging, J Comput Assist Tomogr, 14, 704, 10.1097/00004728-199009000-00004 Salzman, 2005, Giant tumefactive perivascular spaces, AJNR Am J Neuroradiol, 26, 298 Fanous, 2007, Perivascular spaces: normal and giant, Can J Neurol Sci, 34, 5, 10.1017/S0317167100005722 Pomper, 1999, CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography, AJNR Am J Neuroradiol, 20, 75 Harris, 1994, Intracranial vasculitis, Neuroimaging Clin N Am, 4, 773 Lai, 1996, A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis, J Neurol Neurosurg Psychiatry, 60, 339, 10.1136/jnnp.60.3.339 Nesbit, 1991, Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy, Radiology, 180, 467, 10.1148/radiology.180.2.2068314 Kermode, 1990, Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement, Neurology, 40, 229, 10.1212/WNL.40.2.229 Cotton, 2003, MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals, Neurology, 60, 640, 10.1212/01.WNL.0000046587.83503.1E Masdeu, 2000, Multiple sclerosis–when and how to image. American College of Radiology (ACR) Appropriateness Criteria, Radiology, 215, 547 Barkhof, 1992, Meningeal Gd-DTPA enhancement in multiple sclerosis, AJNR Am J Neuroradiol, 13, 397 Demaerel, 1995, Focal leptomeningeal MR enhancement along the chiasm as a presenting sign of multiple sclerosis, J Comput Assist Tomogr, 19, 297, 10.1097/00004728-199503000-00023 Paty, 1988, Magnetic resonance imaging in the assessment of disease activity in multiple sclerosis, Can J Neurol Sci, 15, 266, 10.1017/S0317167100027724 Willoughby, 1989, Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients, Ann Neurol, 25, 43, 10.1002/ana.410250107 Koopmans, 1989, Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features, Ann Neurol, 25, 74, 10.1002/ana.410250112 Paty, 1994, Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis, Ann Neurol, 36, S95, 10.1002/ana.410360721 Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N Engl J Med, 338, 278, 10.1056/NEJM199801293380502 Kutzelnigg, 2005, Cortical demyelination and diffuse white matter injury in multiple sclerosis, Brain, 128, 2705, 10.1093/brain/awh641 Truyen, 1996, Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis, Neurology, 47, 1469, 10.1212/WNL.47.6.1469 van Walderveen, 1999, Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy, Ann Neurol, 46, 79, 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.0.CO;2-9 Uhlenbrock, 1989, The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE), Neuroradiology, 31, 203, 10.1007/BF00344344 Freedman, 2004, Treatment optimization in multiple sclerosis, Can J Neurol Sci, 31, 157, 10.1017/S0317167100053804 Karussis, 2006, A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting, Eur J Neurol, 13, 61, 10.1111/j.1468-1331.2006.01147.x Zhao, 2000, MRI of dirty-appearing white matter in MS, Neurology, 54, A121 Moore GR, Laule C, MacKay A, et al. Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss. J Neurol, in press. Liu, 1999, Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis, J Neurol Neurosurg Psychiatry, 66, 323, 10.1136/jnnp.66.3.323 Filippi, 1998, Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis, J Neurol Sci, 158, 148, 10.1016/S0022-510X(98)00110-5 Miller, 2002, Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance, Brain, 125, 1676, 10.1093/brain/awf177 van Walderveen, 1998, Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study, Eur Neurol, 40, 91, 10.1159/000007964 Brex, 2000, Detection of ventricular enlargement in patients at the earliest clinical stage of MS, Neurology, 54, 1689, 10.1212/WNL.54.8.1689 Fox, 2000, Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI, Neurology, 54, 807, 10.1212/WNL.54.4.807 Rudick, 1999, Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS: Multiple Sclerosis Collaborative Research Group, Neurology, 53, 1698, 10.1212/WNL.53.8.1698 Rovaris, 2001, Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications, Brain, 124, 1803, 10.1093/brain/124.9.1803 Ge, 2000, Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis, Radiology, 214, 665, 10.1148/radiology.214.3.r00mr30665 Miller, 2007, MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS, Neurology, 68, 1390, 10.1212/01.wnl.0000260064.77700.fd Tartaglino, 1995, Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters, Radiology, 195, 725, 10.1148/radiology.195.3.7754002 Bot, 2002, Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging, Radiology, 223, 46, 10.1148/radiol.2231010707 Thielen, 1996, Multiple sclerosis of the spinal cord: magnetic resonance appearance, J Comput Assist Tomogr, 20, 434, 10.1097/00004728-199605000-00022 Lee, 1991, Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, 41, 657, 10.1212/WNL.41.5.657 Thorpe, 1996, Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI, Brain, 119, 709, 10.1093/brain/119.3.709 Dalton, 2003, Spinal cord MRI in clinically isolated optic neuritis, J Neurol Neurosurg Psychiatry, 74, 1577, 10.1136/jnnp.74.11.1577 Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria, Ann Neurol, 58, 840, 10.1002/ana.20703 Lycklama, 2003, Spinal-cord MRI in multiple sclerosis, Lancet Neurol, 2, 555, 10.1016/S1474-4422(03)00504-0 Wingerchuk, 2006, Revised diagnostic criteria for neuromyelitis optica, Neurology, 66, 1485, 10.1212/01.wnl.0000216139.44259.74 Costa, 2007, An unusual chiasmal visual defect in a patient with neuromyelitis optica: case report, Arq Bras Oftalmol, 70, 153, 10.1590/S0004-27492007000100029 Pittock, 2006, Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression, Arch Neurol, 63, 964, 10.1001/archneur.63.7.964 Kepes, 1993, Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients, Ann Neurol, 33, 18, 10.1002/ana.410330105 Capello, 2004, Marburg type and Balo's concentric sclerosis: rare and acute variants of multiple sclerosis, Neurol Sci, 25, S361, 10.1007/s10072-004-0341-1 Canellas, 2007, Idiopathic inflammatory-demyelinating diseases of the central nervous system, Neuroradiology, 49, 393, 10.1007/s00234-007-0216-2 Fisniku, 2008, Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis, Brain, 131, 808, 10.1093/brain/awm329 Cole, 2000, The National Eye Institute visual function questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial, Invest Ophthalmol Vis Sci, 41, 1017 Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol, 13, 227, 10.1002/ana.410130302 Barkhof, 2007, Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results, Arch Neurol, 64, 1292, 10.1001/archneur.64.9.1292 Kappos, 2007, Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study, Lancet, 370, 389, 10.1016/S0140-6736(07)61194-5 Polman, 2008, Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b, J Neurol, 255, 480 Dalton, 2003, New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes, Ann Neurol, 53, 673, 10.1002/ana.10580 Paty, 1988, Magnetic resonance imaging (MRI) in the diagnosis of multiple sclerosis: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and computerized tomography, Neurology, 38, 180, 10.1212/WNL.38.2.180 Fazekas, 1988, Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurology, 38, 1822, 10.1212/WNL.38.12.1822 Frohman, 2003, The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 61, 602, 10.1212/01.WNL.0000082654.99838.EF Jacobs, 2000, Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group, N Engl J Med, 343, 898, 10.1056/NEJM200009283431301 Beck, 2003, High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial, Arch Ophthalmol, 121, 944, 10.1001/archopht.121.7.944 Korteweg, 2006, MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study, Lancet Neurol, 5, 221, 10.1016/S1474-4422(06)70353-2 Uitdehaag, 2004, The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee, Neurology, 63, 1140, 10.1212/WNL.63.6.1140 Schiffer, 1993, Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis, J Neuroimaging, 3, 81, 10.1111/jon19933281 Carmosino, 2005, Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral, Arch Neurol, 62, 585, 10.1001/archneur.62.4.585 Nielsen, 2005, Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria, Ann Neurol, 58, 781, 10.1002/ana.20632 Wolinsky, 2004, The PROMiSe trial: baseline data review and progress report, Mult Scler, 10, S65 de Seze, 2007, Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria, Mult Scler, 13, 622, 10.1177/1352458506071767 Sadovnick, 1993, Epidemiology of multiple sclerosis: a critical overview, Can J Neurol Sci, 20, 17, 10.1017/S0317167100047351 Banwell, 2007, MRI features of pediatric multiple sclerosis, Neurology, 68, S46, 10.1212/01.wnl.0000259406.09052.75 Ghassemi, 2008, Lesion distribution in children with clinically isolated syndromes, Ann Neurol, 63, 401, 10.1002/ana.21322 Mikaeloff, 2004, MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood, Brain, 127, 1942, 10.1093/brain/awh218 Hahn, 2004, MRI criteria for multiple sclerosis: evaluation in a pediatric cohort, Neurology, 62, 806, 10.1212/01.WNL.0000113723.36715.A6 Menge, 2005, Acute disseminated encephalomyelitis: an update, Arch Neurol, 62, 1673, 10.1001/archneur.62.11.1673 Hynson, 2001, Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children, Neurology, 56, 1308, 10.1212/WNL.56.10.1308 McAdam, 2002, Pediatric tumefactive demyelination: case series and review of the literature, Pediatr Neurol, 26, 18, 10.1016/S0887-8994(01)00322-8 Chong, 2006, Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West, Can J Neurol Sci, 33, 95, 10.1017/S0317167100004777 Nakashima, 2006, Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG, J Neurol Neurosurg Psychiatry, 77, 1073, 10.1136/jnnp.2005.080390 Barkhof, 2002, The clinico-radiological paradox in multiple sclerosis revisited, Curr Opin Neurol, 15, 239, 10.1097/00019052-200206000-00003 Petkau, 2008, Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses, Mult Scler, 14, 70, 10.1177/1352458507088104 Filippi, 2001, Non-conventional MR techniques to monitor the evolution of multiple sclerosis, Neurol Sci, 22, 195, 10.1007/s100720170023 Traboulsee, 2003, Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities, Mult Scler, 9, 566, 10.1191/1352458503ms958oa Rieckmann, 2006, Nervenarzt, 77, 1506, 10.1007/s00115-006-2220-x Langer-Gould, 2005, Progressive multifocal leukoencephalopathy in a patient treated with natalizumab, N Engl J Med, 353, 375, 10.1056/NEJMoa051847 Yousry, 2006, Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy, N Engl J Med, 354, 924, 10.1056/NEJMoa054693